albumin/factor IX parenteral; albutrepenonacog alfa (Idelvion)

From Aaushi
Jump to navigation Jump to search

Indications

Pharmacokinetics

More general terms

References

  1. FDA News Release. March 4, 2016 FDA approves first coagulation factor-albumin fusion protein to treat patients with hemophilia B. http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm489266.htm